Search Results - Ghrieb, Zineb

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors

    A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors by Teixeira, Luis, Medioni, Jacques, Garibal, Julie, Adotevi, Olivier, Doucet, Ludovic, Durey, Marie-Agnès Dragon, Ghrieb, Zineb, Kiladjian, Jean-Jacques, Brizard, Mara, Laheurte, Caroline, Wehbe, Maria, Pliquet, Elodie, Escande, Marie, Defrance, Rémy, Culine, Stephane, Oudard, Stephane, Wain-Hobson, Simon, Doppler, Valérie, Huet, Thierry, Langlade-Demoyen, Pierre

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Final Results of Ruxopeg, a Phase 1/2 Adaptive Randomized Trial of Ruxolitinib (Rux) and Pegylated Interferon Alpha (IFNa) 2a in Patients with Myelofibrosis (MF)

    Final Results of Ruxopeg, a Phase 1/2 Adaptive Randomized Trial of Ruxolitinib (Rux) and Pegylated Interferon Alpha (IFNa) 2a in Patients with Myelofibrosis (MF) by Kiladjian, Jean-Jacques, Ianotto, Jean-Christophe, Soret, Juliette, Maslah, Nabih, Chaffaut, Cendrine, Boyer perrard, Françoise, Barraco, Fiorenza, Dubruille, Viviane, Capron, Claude, Tisserand, Amandine, Rolland-Neyret, Valérie, Ghrieb, Zineb, Chevret, Sylvie, Plo, Isabelle, Schlageter, Marie-Hélène, Meignin, Veronique, Resche-Rigon, Matthieu, Cassinat, Bruno

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAF V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism

    Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAF V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism by Louveau, Baptiste, Resche-Rigon, Matthieu, Lesimple, Thierry, Da Meda, Laetitia, Pracht, Marc, Baroudjian, Barouyr, Delyon, Julie, Amini-Adle, Mona, Dutriaux, Caroline, Reger de Moura, Coralie, Sadoux, Aurélie, Jouenne, Fanélie, Ghrieb, Zineb, Vilquin, Paul, Bouton, Didier, Tibi, Annick, Huguet, Samuel, Rezai, Keyvan, Battistella, Maxime, Mourah, Samia, Lebbe, Céleste

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

    Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo by Verger, Emmanuelle, Soret-Dulphy, Juliette, Maslah, Nabih, Roy, Lydia, Rey, Jerome, Ghrieb, Zineb, Kralovics, Robert, Gisslinger, Heinz, Grohmann-Izay, Barbara, Klade, Christoph, Chomienne, Christine, Giraudier, Stéphane, Cassinat, Bruno, Kiladjian, Jean-Jacques

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Abstract 3895: A phase I-II pharmacokinetic drug-drug interaction evaluation of oral palbociclib in combination with vemurafenib in patients suffering metastatic melanoma with BRAF V600 mutated and CDKN2A loss & expression of Rb

    Abstract 3895: A phase I-II pharmacokinetic drug-drug interaction evaluation of oral palbociclib in combination with vemurafenib in patients suffering metastatic melanoma with BRAF... by Huguet, Samuel, Lesimple, Thierry, Geraud, Arthur, Amini-Adle, Mouna, Dutriaux, Caroline, Meda, Laetitia Da, Capelle, Florence, Ghrieb, Zineb, Mourah, Samia, Madar, Olivier, Bouton, Didier, Resche-Rigon, Mathieu, Lebbe, Celest, Rezai, Keyvan

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: